Searched for
ELI LILLY
GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...- Ozempic wave boosts US cobblers and tailors as Americans tighten their beltsConsumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...
- Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
- US stocks today: US stocks end higher as healthcare stocks lift Dow, tech a breatherWall Street ended higher on Tuesday, led by the Dow as investors shifted towards healthcare and other value stocks. The S&P 500 also gained...
- US stocks today: US stocks gain as healthcare stocks hit record high, oil prices fallWall Street's main indexes saw increases driven by a rally in healthcare stocks that reached record highs. Easing oil prices contributed to...
- D-St set for a positive opening as GIFT Nifty signals firm startOn Thursday, market indices Nifty and Sensex experienced notable advances, illustrating a surge in local investor confidence. The Nifty sur...
- US Stock Market: What to led to S&P 500, Nasdaq, Dow Jones, Russell 2000 rebound after historic low despite fall of Nvidia stocks, TSMC shares?US Stock Market today: Nvidia dipped 1.8 per cent after chip manufacturer TSMC struck a cautious note on 2027 despite reporting a sixth con...
- US stocks: Dow, S&P 500 end higher as traders shift from AI to healthcareAfter a rocky start, the S&P 500 experienced a resurgence, largely spurred by investments in the healthcare and consumer segments. Investor...
- AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered a collaboration with insitro to explore new treatment options for challenging liver and heart diseases. The partner...
- AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered into a partnership with insitro to identify treatments for challenging liver and heart diseases. This collaboration...
- Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...
- Our central mission must be patient-centric innovation: JP NaddaJ P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural coho...
- India has biotech talent and know-how, but funding ecosystem lags: Lilly CEOEli Lilly intends to innovate in the weight-loss market, launching up to four new products in the coming years. The success of Mounjaro and...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Smart ring maker Oura, shareholders look to raise up to $2.2 billion in US IPOSmart ring maker Oura plans to raise up to $2.2 billion in its US initial public offering. Eli Lilly and Dragoneer have indicated interest ...
Load More
